133 related articles for article (PubMed ID: 11781281)
1. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
Ougolkov AV; Yamashita K; Mai M; Minamoto T
Gastroenterology; 2002 Jan; 122(1):60-71. PubMed ID: 11781281
[TBL] [Abstract][Full Text] [Related]
2. beta-Catenin and ras oncogenes detect most human colorectal cancer.
Zhang B; Ougolkov A; Yamashita K; Takahashi Y; Mai M; Minamoto T
Clin Cancer Res; 2003 Aug; 9(8):3073-9. PubMed ID: 12912959
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study.
Resnick MB; Routhier J; Konkin T; Sabo E; Pricolo VE
Clin Cancer Res; 2004 May; 10(9):3069-75. PubMed ID: 15131045
[TBL] [Abstract][Full Text] [Related]
4. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
[TBL] [Abstract][Full Text] [Related]
5. Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas.
Bondi J; Bukholm G; Nesland JM; Bukholm IR
APMIS; 2004 Jan; 112(1):49-56. PubMed ID: 14961975
[TBL] [Abstract][Full Text] [Related]
6. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
7. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
Brabletz T; Jung A; Dag S; Reu S; Kirchner T
Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438
[TBL] [Abstract][Full Text] [Related]
8. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.
Baldus SE; Mönig SP; Huxel S; Landsberg S; Hanisch FG; Engelmann K; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Clin Cancer Res; 2004 Apr; 10(8):2790-6. PubMed ID: 15102686
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of oncogenesis in colon versus rectal cancer.
Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic beta-catenin activation.
Yamashita K; Ougolkov AV; Nakazato H; Ito K; Ohashi Y; Kitakata H; Yasumoto K; Omote K; Mai M; Takahashi Y; Minamoto T
Dis Colon Rectum; 2007 Aug; 50(8):1169-81. PubMed ID: 17347903
[TBL] [Abstract][Full Text] [Related]
11. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM
Mol Cell Biol; 2001 Feb; 21(4):1370-83. PubMed ID: 11158322
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas.
Hommura F; Furuuchi K; Yamazaki K; Ogura S; Kinoshita I; Shimizu M; Moriuchi T; Katoh H; Nishimura M; Dosaka-Akita H
Cancer; 2002 Feb; 94(3):752-8. PubMed ID: 11857309
[TBL] [Abstract][Full Text] [Related]
14. Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Saeki H; Tanaka S; Sugimachi K; Kimura Y; Miyazaki M; Ohga T; Sugimachi K
Dig Dis Sci; 2002 Dec; 47(12):2738-42. PubMed ID: 12498294
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.
Maruyama K; Ochiai A; Akimoto S; Nakamura S; Baba S; Moriya Y; Hirohashi S
Oncology; 2000 Nov; 59(4):302-9. PubMed ID: 11096342
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Li YJ; Wei ZM; Meng YX; Ji XR
World J Gastroenterol; 2005 Apr; 11(14):2117-23. PubMed ID: 15810077
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
Yang B; Tang F; Zhang B; Zhao Y; Feng J; Rao Z
World J Surg Oncol; 2014 Jan; 12():24. PubMed ID: 24476461
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O; Schlamp A; Broll R; Bruch HP
Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
[TBL] [Abstract][Full Text] [Related]
19. Cadherin-catenin expression in primary colorectal cancer: a survival analysis.
Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR
Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114
[TBL] [Abstract][Full Text] [Related]
20. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A
Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
